Status:
ENROLLING_BY_INVITATION
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Multiple Sclerosis
Neuromyelitis Optica
Eligibility:
All Genders
18+ years
Brief Summary
In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mechanisms, and clinical implications of ce...
Eligibility Criteria
Inclusion
- 18 years old
- able to provide consent in English
- able to undergo MRI
Exclusion
- contraindication to MRI
- pregnancy
Key Trial Info
Start Date :
May 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2034
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT05982925
Start Date
May 6 2022
End Date
July 31 2034
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029